Federal clinical recommendations on diagnostics and treatment of Graves' disease in the children
https://doi.org/10.14341/probl201460359-68
Abstract
Graves' disease is rather rare occurrence in the childhood, with the girls being the most frequently affected gender. The draft clinical guidelines on diagnostics and treatment of Graves' disease in the children and adolescents are proposed for the extensive discussion. The guidelines are intended for pediatric endocrinologists, pediatrists, surgeons, and specialists in radioisotope therapy.
References
1. Дедов И.И., Петеркова В.А. Детская эндокринология. Руководство для врачей. – М.: УП-Принт; 2006. 595с. [Dedov II, Peterkova VA. Pediatric endocrinology. Guidance for doctors. Moscow: UP-Print; 2006. 595p.]
2. Эндокринология. Национальное руководство. / Под редакцией акад. РАН и РАМН И.И.Дедова, чл.-кор. РАМН Г.А.Мельниченко. / Подготовлено под эгидой Российской ассоциации эндокринологов и Ассоциации медицинских обществ по качеству. — М: ГЭОТАР-Медиа, 2011.
3. [Endocrinology. National Guidelines. Ed by I.I.Dedov, G.A.Melnichenko. Moscow: GEOTAR-Media; 2011.]
4. Ajjan RA, Weetman AP. Techniques to quantify TSH receptor antibodies. Nature Clinical Practice Endocrinology & Metabolism. 2008;4(8):461-8. doi: 10.1038/ncpendmet0886
5. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593-646. doi: 10.1089/thy.2010.0417
6. Bergman P, Auldist AW, Cameron F. Review of the outcome of management of Graves' disease in children and adolescents. J Paediatr Child Health. 2001;37(2):176-82. doi: 10.1046/j.1440-1754.2001.00641.x
7. Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr Opin Pediatr. 2009;21(4):523-8. doi: 10.1097/MOP.0b013e32832cf824
8. Brown RS. Disorders of the Thyroid Gland in Infants, Children, and Adolescents. In DeGroot LJ. Thyroid Disease Manager. South Dartmouth: Endocrine Education, Inc.; 2012. Available on: http://www.thyroidmanager.org/chapter/disorders-of-the-thyroid-gland-in-infancy-childhood-and-adolescence/
9. Cappelli C, Gandossi E, Castellano M, Pizzocaro C, Agosti B, Delbarba A, et al. Prognostic Value of Thyrotropin Receptor Antibodies (TRAb) in Graves' Disease: A 120 Months Prospective Study. Endocr J. 2007;54(5):713-20. doi: 10.1507/endocrj.K06-069
10. Cooper DS, Rivkees SA. Putting Propylthiouracil in Perspective. The Journal of Clinical Endocrinology & Metabolism. 2009;94(6):1881-2. doi: 10.1210/jc.2009-0850
11. Glaser NS, Styne DM. Predicting the Likelihood of Remission in Children With Graves' Disease: A Prospective, Multicenter Study. Pediatrics. 2008;121(3):e481-e8. doi: 10.1542/peds.2007-1535
12. Hamburger JI. Management of Hyperthyroidism in Children and Adolescents. The Journal of Clinical Endocrinology & Metabolism. 1985;60(5):1019-24. doi: 10.1210/jcem-60-5-1019
13. Hermsen D, Eckstein A, Schinner S, Willenberg H, Thiel A, Scherbaum W, et al. Reproducibility of Elecsys®Anti-TSHR Test Results in a Lot-to-Lot Comparison. Horm Metab Res. 2010;42(04):295-7. doi: 10.1055/s-0029-1246188
14. Kaguelidou F, Alberti C, Castanet M, Guitteny M-A, Czernichow P, Léger J. Predictors of Autoimmune Hyperthyroidism Relapse in Children after Discontinuation of Antithyroid Drug Treatment. The Journal of Clinical Endocrinology & Metabolism. 2008;93(10):3817-26. doi: 10.1210/jc.2008-0842
15. Kaguelidou F, Carel JC, eacute, ger J. Graves’ Disease in Childhood: Advances in Management with Antithyroid Drug Therapy. Horm Res. 2009;71(6):310-7. doi: 10.1159/000223414
16. Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in Children Treated with Long Term Medical Therapy: Twenty-Five Percent Remission Every Two Years*. The Journal of Clinical Endocrinology & Metabolism. 1987;64(6):1241-5. doi: 10.1210/jcem-64-6-1241
17. Lytton SD, Kahaly GJ. Bioassays for TSH-receptor autoantibodies: An update. Autoimmunity Reviews. 2010;10(2):116-22. doi: 10.1016/j.autrev.2010.08.018
18. Pedersen IB, Handberg A, Knudsen N, Heickendorff L, Laurberg P. Assays for Thyroid-Stimulating Hormone Receptor Antibodies Employing Different Ligands and Ligand Partners May Have Similar Sensitivity and Specificity but Are Not Interchangeable. Thyroid. 2010;20(2):127-33. doi: 10.1089/thy.2009.0105
19. Rahhal SN, Eugster EA. Thyroid Stimulating Immunoglobulin is Often Negative in Children with Graves' Disease. J Pediatr Endocrinol Metab. 2008;21(11). doi: 10.1515/jpem.2008.21.11.1085
20. Raza J, Hindmarsh PC, Brook CGD. Thyrotoxicosis in children: thirty years’experience. Acta Paediatr. 2007;88(9):937-41. doi: 10.1111/j.1651-2227.1999.tb00185.x
21. Rivkees SA, Cornelius EA. Influence of Iodine-131 Dose on the Outcome of Hyperthyroidism in Children. Pediatrics. 2003;111(4):745-9. doi: 10.1542/peds.111.4.745
22. Rivkees SA, Dinauer C. An Optimal Treatment for Pediatric Graves’ Disease Is Radioiodine. The Journal of Clinical Endocrinology & Metabolism. 2007;92(3):797-800. doi: 10.1210/jc.2006-1239
23. Rivkees SA, Sklar C, Freemark M. The Management of Graves’ Disease in Children, with Special Emphasis on Radioiodine Treatment. The Journal of Clinical Endocrinology & Metabolism. 1998;83(11):3767-76. doi: 10.1210/jcem.83.11.5239
24. Rivkees S, Stephenson K, Dinauer C. Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children. Int J Pediatr Endocrinol. 2010;2010(1):176970. doi: 10.1186/1687-9856-2010-176970
25. Rivkees SA, Szarfman A. Dissimilar Hepatotoxicity Profiles of Propylthiouracil and Methimazole in Children. The Journal of Clinical Endocrinology & Metabolism. 2010;95(7):3260-7. doi: 10.1210/jc.2009-2546
26. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, et al. Thyroid Cancer after Exposure to External Radiation: A Pooled Analysis of Seven Studies. Radiat Res. 1995;141(3):259. doi: 10.2307/3579003
27. Segni M, Leonardi E, Mazzoncini B, Pucarelli IDA, Pasquino AM. Special Features of Graves' Disease in Early Childhood. Thyroid. 1999;9(9):871-7. doi: 10.1089/thy.1999.9.871
28. Sherman J, Thompson GB, Lteif A, Schwenk WF, van Heerden J, Farley DR, et al. Surgical management of Graves disease in childhood and adolescence: an institutional experience. Surgery. 2006;140(6):1056-62. doi: 10.1016/j.surg.2006.07.040
29. Shulman DI, Muhar IVY, Jorgensen EV, Diamond FB, Bercu BB, Root AW. Autoimmune Hyperthyroidism in Prepubertal Children and Adolescents: Comparison of Clinical and Biochemical Features at Diagnosis and Responses to Medical Therapy. Thyroid. 1997;7(5):755-60. doi: 10.1089/thy.1997.7.755
30. Smith J, Brown RS. Persistence of Thyrotropin (TSH) Receptor Antibodies in Children and Adolescents with Graves' Disease Treated Using Antithyroid Medication. Thyroid. 2007;17(11):1103-7. doi: 10.1089/thy.2007.0072
31. Smith BR, Sanders J, Furmaniak J. TSH Receptor Antibodies. Thyroid. 2007;17(10):923-38. doi: 10.1089/thy.2007.0239
32. Zöphel K, Roggenbuck D, Wunderlich G, Schott M. Continuously Increasing Sensitivity over Three Generations of TSH Receptor Autoantibody Assays. Horm Metab Res. 2010;42(12):900-2. doi: 10.1055/s-0030-1267171
Review
For citations:
Bezlepkina O.B. Federal clinical recommendations on diagnostics and treatment of Graves' disease in the children. Problems of Endocrinology. 2014;60(3):59-68. (In Russ.) https://doi.org/10.14341/probl201460359-68
Views:
3507
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
